Real-world use of oral semaglutide in adults with type 2 diabetes.

Roslind K, Bodholdt U, Damgaard T, Jensen C.

DOI: 10.61409/a06250520
Published: 2026-06-16
Container: Dan Med J
Publisher: Not recorded
Open access: no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.61409/a06250520,
  title = {Real-world use of oral semaglutide in adults with type 2 diabetes.},
  author = {Roslind K and  Bodholdt U and  Damgaard T and  Jensen C.},
  year = {2026},
  journal = {Dan Med J},
  doi = {10.61409/a06250520},
  url = {https://doi.org/10.61409/a06250520}
}

RIS

TY  - JOUR
TI  - Real-world use of oral semaglutide in adults with type 2 diabetes.
AU  - Roslind K
AU  -  Bodholdt U
AU  -  Damgaard T
AU  -  Jensen C.
PY  - 2026
JO  - Dan Med J
DO  - 10.61409/a06250520
UR  - https://doi.org/10.61409/a06250520
ER  -

APA

K, R., U, B., T, D., & C., J. (2026). Real-world use of oral semaglutide in adults with type 2 diabetes.. Dan Med J. https://doi.org/10.61409/a06250520

Source records

europe-pmc · retrieved 2026-09-26T19:30:19.726Z